The WANTAI SARS-CoV-2 Rapid Test is a rapid diagnostic test for the qualitative detection of SARS-COV-2 virus antigen in nasopharyngeal or oropharyngeal swab specimens.
The test provides very accurate results in few minutes, without the need for additional laboratory equipment.
The diagnostic sensitivity is up to 97.50% and the diagnostic specificity is> 99.9%. This means that positive antigen test results are very accurate.
Beijing Wantai Biological Pharmaceutical Co., Ltd. is a renowned company for the production of medical technologies based in the People's Republic of China. Among other things, the company delivered tests for general immunity testing in the spring of this year. According to the results of the study, their tests were rated as highly reliable
No cross-reactivity was found with human pathogenic coronaviruses (such as hCoV-229E, -HKU1, -NL63, and -OC43) or influenza viruses.